Every day, we sift through the filings to spot where the real conviction lies β cutting through the noise to highlight the most meaningful insider moves.
π Zenas Biopharma $ZBIO β CEO purchased $1.07 Million via Form 4.
A clear signal from the topβthe CEO putting real money to work in the recent-issue biotech as it continues to find its footing post-IPO.
π Sonoco Products $SON β James A. Harrell III purchased $340,183 via Form 4.
Another insider stepping in within the packaging name, adding to the ongoing trend of accumulation.
Hereβs The Hot Corner, with data from April 28, 2026:
π Huntington Bancshares $HBAN β James D. Rollins III purchased $111,085 via Form 4.
A smaller insider buy in the regional bank, with shares sitting near the upper end of a multi-year base.
π Janux Therapeutics $JANX β Point72 Asset Management increased its stake from 1.60% to 5.00% via 13G.
The multi-strategy fund crosses the key 5% threshold, building a meaningful position in the choppy biotech name.
